Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Market Cap: 47.8m AUD

Relative Value

PAL price has not been updated for more than 5 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of PAL.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PAL Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

PAL Competitors Multiples
Palla Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Palla Pharma Ltd
ASX:PAL
47.8m AUD 2.8 -0.8 -2 -2
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 446.2 5 285.9 1 550 3 114
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.7B USD 5.5 36.7 25.9 33.5
US
Danaher Corp
NYSE:DHR
170.5B USD 7 48.6 25.9 39.2
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.5 29.2 16.9 22.5
CH
Lonza Group AG
SIX:LONN
38.3B CHF 5.4 52.1 39.8 39.8
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD 2.6 31.9 15.3 22.9
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY 6.3 18.6 18.8 18.8
US
Agilent Technologies Inc
NYSE:A
39.6B USD 5.7 30.4 23.5 28
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD 7.5 35.3 25.4 28.2
US
Waters Corp
NYSE:WAT
23.6B USD 7.6 36.6 23.6 29.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Palla Pharma Ltd
ASX:PAL
Average EV/EBITDA: 176.5
Negative Multiple: -2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 550
5%
310
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.9
6%
4.3
US
Danaher Corp
NYSE:DHR
25.9
5%
5.2
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
CH
Lonza Group AG
SIX:LONN
39.8
18%
2.2
US
IQVIA Holdings Inc
NYSE:IQV
15.3
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
18.8
30%
0.6
US
Agilent Technologies Inc
NYSE:A
23.5
13%
1.8
US
Mettler-Toledo International Inc
NYSE:MTD
25.4
4%
6.4
US
Waters Corp
NYSE:WAT
23.6
11%
2.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Palla Pharma Ltd
ASX:PAL
Average EV/EBIT: 337.6
Negative Multiple: -2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 114
29%
107.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
33.5
15%
2.2
US
Danaher Corp
NYSE:DHR
39.2
16%
2.5
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
CH
Lonza Group AG
SIX:LONN
39.8
22%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
22.9
15%
1.5
CN
WuXi AppTec Co Ltd
SSE:603259
18.8
23%
0.8
US
Agilent Technologies Inc
NYSE:A
28
23%
1.2
US
Mettler-Toledo International Inc
NYSE:MTD
28.2
5%
5.6
US
Waters Corp
NYSE:WAT
29.4
14%
2.1